BMY Stock: Analysts See 16% Upside and a Strong Buy [Yahoo! Finance]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
reaching $7.39B, up 16% year-over-year and now 50% of total revenue, while Breyanzi grew 49%, Camzyos 59%, and Opdualag 38% in the quarter. Bristol Myers Squibb's pipeline has multiple pivotal readouts expected in the back half of 2026, including Iberdomide FDA decision in August and Milvexian stroke prevention trial results, positioning the company for potential industry-leading growth into the 2030s despite legacy product erosion and $49B debt load. The analyst who called NVIDIA in 2010 just named his top 10 AI stocks. Get them here FREE Bristol-Myers Squibb NYSE:BMY ) trades at $60.17 as of writing. The 24/7 Wall St. Price Target is $70.12, implying upside of 16.51% over the next 12 months. The 24/7 Wall St. model rating is buy, with a high (90%) confidence level. Metric Value Current Price 24/7 Wall St. Price Target Upside/Downside Model Rating BUY Confidence Level Bristol-Myers Squibb is a large-cap pharmaceutical company in portfolio transition. Its Growt
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Moderna's mRNA Melanoma Data And Fast Track Status Shape Oncology Story [Yahoo! Finance]Yahoo! Finance
- Bristol Myers Squibb (BMY) was upgraded by <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=BMY&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall Street Zen</a> from "buy" MarketBeat
- Bristol-Myers Squibb Collaboration Adds New Dimension To Oncology Valuation Story [Yahoo! Finance]Yahoo! Finance
- Bristol-Myers Squibb: The Market Is Not Pricing The Growth Portfolio That Replaces The Patent Cliff [Seeking Alpha]Seeking Alpha
- The innovators working to make in vivo cell therapy a reality [Yahoo! Finance]Yahoo! Finance
BMY
Earnings
- 2/6/26 - Beat
BMY
Sec Filings
- 4/17/26 - Form DEFA14A
- 4/2/26 - Form 4
- 4/2/26 - Form 4
- BMY's page on the SEC website